FIELD: medicine.
SUBSTANCE: method involves determining total uronic acids concentration in diurnal urine The value being greater than 6.0 mg/day during active disease stage and greater than 3.0 mg/day during remission stage, progressing or recurrent autoimmune ophthalmopathy clinical course.
EFFECT: high accuracy in predicting disease clinical course at any disease stage.
3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ENDOCRINE OPHTHALMOPATHY IN PATIENTS WITH GRAVES DISEASE BY DETECTING ANTI-THYROID PEROXIDASE ANTIBODIES | 2011 |
|
RU2460072C1 |
| METHOD FOR PREDICTION OF PESPONSE RATE TO IMMUNOSUPPRESSIVE THERAPY OF CHRONIC GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME | 2011 |
|
RU2453852C1 |
| METHOD FOR PREDICTING DIFFUSE TOXIC GOITER CLINICAL COURSE | 2005 |
|
RU2291434C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RELAPSE IN THE MEDICAL TREATMENT OF GRAVES' DISEASE | 2021 |
|
RU2778614C1 |
| METHOD OF DETERMINING THE PHASE OF DEVELOPMENT OF DUODENAL CELLS | 0 |
|
SU1439504A1 |
| METHOD OF TREATMENT FOR AUTOIMMUNE OOPHORITIS OF INFLAMMATION GENESIS FOR WOMEN OF CHILDBEARING AGE | 2008 |
|
RU2370278C1 |
| METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
| METHOD OF PREDICTING PROGRESSING COURSE OF STEROID-RESISTANT NEPHROTIC SYNDROME IN CASE OF GLOMERULONEPHRITIS IN CHILDREN | 2009 |
|
RU2414852C1 |
| METHOD FOR SURGICAL TREATMENT OF THYROID CANCER IN THYROTOXICOSIS | 2020 |
|
RU2751971C1 |
| METHOD FOR ENDOCRINE OPHTHALMOPATHY EARLIEST MANIFESTATIONS DIAGNOSING | 2016 |
|
RU2617198C1 |
